Clinical Trial Update: Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SQ109, high-dose Rifampicin, and Moxifloxacin in adults with smear-positive pulmonary tuberculosis using a multi-arm multi-sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis Pulmonary

Drugs mentioned

• Moxifloxacin (moxifloxacin)
• Rifampicin
• SQ109 (SQ109)

Snippet

Sponsor: Michael Hoelscher | Conditions: Tuberculosis, Pulmonary | Phase 2 | Status: COMPLETED | Results posted: 2017-09-20